利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

230 条记录 (耗时 0.029 秒)

    NUTRACEUTICAL CONFECTIONARY COMPOSITION CONTAINING CAFFEINE AND L-THEANINE
    1.
    发明申请
    NUTRACEUTICAL CONFECTIONARY COMPOSITION CONTAINING CAFFEINE AND L-THEANINE 审中-公开
    含咖啡因和L-茶氨酸的营养组合物

    公开(公告)号：WO2017105564A1

    公开(公告)日：2017-06-22

    申请号：PCT/US2016/050822

    申请日：2016-09-08

    申请人： NEUROGUM, LLC

    发明人： YOSHIMURA, Kent ,  CHEN, Ryan

    IPC分类号： A23G4/06 ,  A23P10/20 ,  A23P20/20 ,  A61K9/68

    CPC分类号： A61K9/0058 ,  A23G4/068 ,  A23G4/14 ,  A23L33/105 ,  A23L33/175 ,  A23V2002/00 ,  A61K9/2086 ,  A61K9/2095 ,  A61K31/198 ,  A61K31/522 ,  A23V2200/3204 ,  A23V2200/322 ,  A23V2200/33 ,  A23V2250/0646 ,  A23V2250/2108 ,  A23V2250/7052 ,  A23V2250/706 ,  A61K2300/00

    摘要： In general, certain embodiments of the present disclosure provide compositions or mechanisms for oral administration of caffeine via a functional nutraceutical confectionary composition. According to various embodiments, a nutraceutical confectionary composition is provided with a ratio of caffeine to L-theanine ranging from about 1:1 to about 1:2. In some embodiments, the ratio of caffeine to L-theanine is about 2:3. In various embodiments, the nutraceutical confectionary composition may provide caffeine in a range from about 5 mg to about 100 mg per serving. L-theanine may be provided in a range from about 5 mg to about 200 mg per serving. In some embodiments, caffeine may comprise about 0.8% to 10% by weight of the composition; and L-theanine may comprise about 1.2% to 20% by weight of the composition. In certain embodiments, the nutraceutical confectionary composition may comprise a chewing gum.

    摘要翻译： 一般而言，本公开的某些实施方案提供了用于经由功能性营养保健品糖果组合物口服咖啡因的组合物或机制。 根据各种实施方案，提供了营养保健品糖食组合物，咖啡因与L-茶氨酸的比率在约1：1至约1：2的范围内。 在一些实施方案中，咖啡因与L-茶氨酸的比例为约2：3。 在各种实施方案中，营养食品糖果组合物可以提供每份约5mg至约100mg范围内的咖啡因。 L-茶氨酸可以以每份约5mg至约200mg的范围提供。 在一些实施方案中，咖啡因可占组合物的约0.8重量％至10重量％ 并且L-茶氨酸可占组合物重量的约1.2％至20％。 在某些实施方案中，营养保健品糖果组合物可以包含口香糖。

    MATERNAL VITAMIN B6 ADMINISTRATION FOR THE PREVENTION OF INCREASED ADIPOSITY, OVERWEIGHT OR OBESITY IN THE OFFSPRING
    2.
    发明申请
    MATERNAL VITAMIN B6 ADMINISTRATION FOR THE PREVENTION OF INCREASED ADIPOSITY, OVERWEIGHT OR OBESITY IN THE OFFSPRING 审中-公开
    维生素B6用于防止增加的药物，过度或肥胖的药物

    公开(公告)号：WO2015104390A1

    公开(公告)日：2015-07-16

    申请号：PCT/EP2015/050358

    申请日：2015-01-09

    申请人： NESTEC S.A.

    发明人： COOPER, Cyrus ,  GLUCKMAN, Peter David ,  GODFREY, Keith Malcolm ,  MACE, Catherine ,  SILVA ZOLEZZI, Irma

    IPC分类号： A61K31/4415 ,  A23L1/302 ,  A61P3/00 ,  A61P3/04 ,  A61P3/08 ,  A61P3/10

    CPC分类号： A61K31/4415 ,  A23L33/15 ,  A23L33/30 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/326 ,  A23V2200/3262 ,  A23V2200/328 ,  A23V2250/7052 ,  A23V2200/332

    摘要： The present invention generally relates to the early prevention of overweight, obesity,excessive fat accumulation and/or associated metabolic disorders in infants or children. For example, the present invention relates to the prevention of overweight, obesity,excessive fat accumulation and/or associated metabolic disorders in infants or children through appropriate nutrition for women desiring to get pregnant and/or during pregnancy and/or lactation. Embodiments of the present invention relate to the Vitamin B6 for use in the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in the offspring, wherein the vitamin B6 is administered to women desiring to get pregnant and/or to the mother during pregnancy and/or lactation and to maternal food compositions that can be used for this purpose.

    摘要翻译： 本发明一般涉及早期预防婴儿或儿童中超重，肥胖，过度脂肪蓄积和/或相关的代谢紊乱。 例如，本发明涉及通过对期望怀孕和/或在怀孕和/或哺乳期间的妇女的适当营养来预防婴儿或儿童中的超重，肥胖，过度脂肪堆积和/或相关的代谢紊乱。 本发明的实施方案涉及用于预防后代中的超重，肥胖，过多的脂肪蓄积和/或相关的代谢紊乱的维生素B6，其中将维生素B6施用于希望怀孕的妇女和/或 怀孕期间和/或哺乳期的母亲以及可用于此目的的母体食物组合物。